Skip to main content
. 2022 Sep 22;11(19):5554. doi: 10.3390/jcm11195554

Figure 1.

Figure 1

Overall survival of patients who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.